95 related articles for article (PubMed ID: 2576351)
1. Analysis of the estrogen receptor gene structure in human breast cancer.
Koh EH; Ro J; Wildrick DM; Hortobagyi GN; Blick M
Anticancer Res; 1989; 9(6):1841-5. PubMed ID: 2576351
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the PvuII restriction fragment-length polymorphism and exon structure of the estrogen receptor gene in breast cancer and peripheral blood.
Yaich L; Dupont WD; Cavener DR; Parl FF
Cancer Res; 1992 Jan; 52(1):77-83. PubMed ID: 1345763
[TBL] [Abstract][Full Text] [Related]
3. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
[TBL] [Abstract][Full Text] [Related]
4. Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q.
Devilee P; van Vliet M; van Sloun P; Kuipers Dijkshoorn N; Hermans J; Pearson PL; Cornelisse CJ
Oncogene; 1991 Sep; 6(9):1705-11. PubMed ID: 1681492
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor expression in human breast cancer associated with an estrogen receptor gene restriction fragment length polymorphism.
Hill SM; Fuqua SA; Chamness GC; Greene GL; McGuire WL
Cancer Res; 1989 Jan; 49(1):145-8. PubMed ID: 2562795
[TBL] [Abstract][Full Text] [Related]
6. Monoallelic amplification of estrogen receptor-alpha expression in breast cancer.
Schuur ER; Weigel RJ
Cancer Res; 2000 May; 60(10):2598-601. PubMed ID: 10825128
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor gene methylation in human breast tumors.
Falette NS; Fuqua SA; Chamness GC; Cheah MS; Greene GL; McGuire WL
Cancer Res; 1990 Jul; 50(13):3974-8. PubMed ID: 2354445
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in ER-alpha gene interact with estrogen receptor status in breast cancer survival.
Boyapati SM; Shu XO; Ruan ZX; Cai Q; Smith JR; Wen W; Gao YT; Zheng W
Clin Cancer Res; 2005 Feb; 11(3):1093-8. PubMed ID: 15709176
[TBL] [Abstract][Full Text] [Related]
9. Frequent loss of heterozygosity on chromosomes 6q, 11, and 17 in human ovarian carcinomas.
Lee JH; Kavanagh JJ; Wildrick DM; Wharton JT; Blick M
Cancer Res; 1990 May; 50(9):2724-8. PubMed ID: 2328498
[TBL] [Abstract][Full Text] [Related]
10. Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells.
Gudas JM; Klein RC; Oka M; Cowan KH
Clin Cancer Res; 1995 Feb; 1(2):235-43. PubMed ID: 9815978
[TBL] [Abstract][Full Text] [Related]
11. [The expression of c-myb is strongly associated with the presence of estrogen and progesterone receptors in breast cancer].
Guerin M; Barrois M; Riou G
C R Acad Sci III; 1988; 307(20):855-61. PubMed ID: 2907731
[TBL] [Abstract][Full Text] [Related]
12. Somatic change in the estrogen receptor gene associated with altered expression of the progesterone receptor.
Wanless C; Barker S; Puddefoot JR; Panahy C; Goode AW; Vinson GP; Phillips IR
Anticancer Res; 1991; 11(1):139-42. PubMed ID: 2018347
[TBL] [Abstract][Full Text] [Related]
13. [Molecular analysis of the estrogen receptor (ER) gene in association with ER negativity in breast cancer].
Iwase H; Kobayashi S; Iwata H; Yamashita T; Ito K; Toyama T; Hara Y; Greenman J; Mathew CG
Gan To Kagaku Ryoho; 1996 Mar; 23 Suppl 1():61-5. PubMed ID: 8702313
[TBL] [Abstract][Full Text] [Related]
14. A study of chromosome 6 allele loss in human colorectal carcinomas.
Wildrick DM; Alfaro SR; Gope R; Boman BM
Anticancer Res; 1992; 12(5):1717-9. PubMed ID: 1332582
[TBL] [Abstract][Full Text] [Related]
15. Loss of a c-H-ras-1 allele and aggressive human primary breast carcinomas.
Theillet C; Lidereau R; Escot C; Hutzell P; Brunet M; Gest J; Schlom J; Callahan R
Cancer Res; 1986 Sep; 46(9):4776-81. PubMed ID: 3524819
[TBL] [Abstract][Full Text] [Related]
16. c-Ha-ras-1 polymorphism in human breast carcinomas: evidence for a normal distribution of alleles.
Sheng ZM; Guerin M; Gabillot M; Spielmann M; Riou G
Oncogene Res; 1988 Feb; 2(3):245-50. PubMed ID: 2897104
[TBL] [Abstract][Full Text] [Related]
17. A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locus.
Jacobs IJ; Smith SA; Wiseman RW; Futreal PA; Harrington T; Osborne RJ; Leech V; Molyneux A; Berchuck A; Ponder BA
Cancer Res; 1993 Mar; 53(6):1218-21. PubMed ID: 8095178
[TBL] [Abstract][Full Text] [Related]
18. Loss and gain of distinct regions of chromosome 1q in primary breast cancer.
Bièche I; Champème MH; Lidereau R
Clin Cancer Res; 1995 Jan; 1(1):123-7. PubMed ID: 9815894
[TBL] [Abstract][Full Text] [Related]
19. Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters.
Phelan CM; Borg A; Cuny M; Crichton DN; Baldersson T; Andersen TI; Caligo MA; Lidereau R; Lindblom A; Seitz S; Kelsell D; Hamann U; Rio P; Thorlacius S; Papp J; Olah E; Ponder B; Bignon YJ; Scherneck S; Barkardottir R; Borresen-Dale AL; Eyfjörd J; Theillet C; Thompson AM; Larsson C
Cancer Res; 1998 Mar; 58(5):1004-12. PubMed ID: 9500463
[TBL] [Abstract][Full Text] [Related]
20. Allele loss at the c-Ha-ras1 locus in human ovarian cancer.
Lee JH; Kavanagh JJ; Wharton JT; Wildrick DM; Blick M
Cancer Res; 1989 Mar; 49(5):1220-2. PubMed ID: 2917352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
